Tempest Therapeutics, Inc. (TPST) Net margin 2016–2017
Tempest Therapeutics, Inc. (TPST) net profit margin by fiscal year — reported net income divided by reported revenue.
-28670.5%FY2017 · since FY2016: -12597.2% → -28670.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -28670.5% | -16073.3 pp |
| FY2016 | -12597.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net incomeTPST Gross profitTPST Gross marginTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Return on equityTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Total liabilitiesTPST Shareholders’ equityTPST overview →